DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA.
Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Thromb Haemost 1997;
77 (04) 741-747
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.